Eur Rev Med Pharmacol Sci 2014; 18 (19): 2798-2802

Management of malignant bowel obstruction with decompression tubes

L.-J. Hu, S.-Y. Yu

Department of Oncology, Xuzhou Central Hospital, Xuzhou, Jiangsu, China. lylyly7011@163.com


OBJECTIVE: To build a quantitative assessment system for normative cancer pain management.

PATIENTS AND METHODS: Two groups of 60 patients with malignant lower bowel obstruction were formed: the study group (n=30) patients receiving routine small intestinal decompression and enteral nutrition, and the control group (n=30) patients receiving nasogastric decompression and parenteral nutrition. The weight, protein indicators and occurrence of complications in the two groups were compared during the treatment.

RESULTS: The weight gain, increase of albumin and prealbumin, and complication rate were (1.9667 ± 1.38298) kg, (2.9133 ± 1.38258) g/L, (18.5333 ± 10.92840) mg/L and 26.67% in the study group compared with (0.6667±0.87428) kg, (1.5500 ± 0.72099) g/L, (12.9333 ± 8.47688) mg/L and 86.67% in the control group. There were statistically significant differences (t = -4,352,-4.789, -2.218; χ2 = 21.9910; p < 0.05 or p < 0.01) between the two groups.

CONCLUSIONS: The application of small bowel decompression tubes can improve the nutritional status, physical fitness, reduce complications in patients with malignant lower intestinal obstruction.

Free PDF Download

To cite this article

L.-J. Hu, S.-Y. Yu
Management of malignant bowel obstruction with decompression tubes

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 19
Pages: 2798-2802